Meihua International Medical Technologies Co., Ltd. (MHUAF)
OTCMKTS · Delayed Price · Currency is USD
7.13
+0.63 (9.69%)
At close: Aug 21, 2026
MHUAF Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 15.15 | 15.96 | 15.56 | 26.74 | 8.15 |
Cash & Short-Term Investments | 15.15 | 15.96 | 15.56 | 26.74 | 8.15 |
Cash Growth | -5.05% | 2.57% | -41.80% | 228.09% | 13.38% |
Accounts Receivable | 97.89 | 97.95 | 99.46 | 91.03 | 86.48 |
Other Receivables | - | - | 14.23 | - | 0.12 |
Receivables | 107.9 | 104.81 | 113.69 | 91.03 | 86.6 |
Inventory | 1.7 | 1.41 | 1.62 | 1.12 | 1.25 |
Restricted Cash | - | 1.33 | 1.37 | - | - |
Other Current Assets | 28.83 | 19.93 | - | 16.43 | 1.28 |
Total Current Assets | 153.58 | 143.44 | 132.24 | 135.32 | 97.28 |
Property, Plant & Equipment | 7.7 | 7.89 | 8.84 | 8.76 | 7.48 |
Long-Term Investments | 23.45 | 22.39 | 6.13 | 6.67 | 0.94 |
Other Intangible Assets | 0.45 | 0.44 | 3.92 | 0.5 | 0.56 |
Long-Term Deferred Tax Assets | - | 0.99 | 0.37 | - | - |
Other Long-Term Assets | 22 | 11.09 | 20.42 | 12.33 | 30.6 |
Total Assets | 207.18 | 186.24 | 171.92 | 163.58 | 136.86 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 8.42 | 15.48 | 15.82 | 16.1 | 20.98 |
Accrued Expenses | 0.74 | 1.73 | 1.25 | 1.3 | 1.41 |
Short-Term Debt | 8.99 | 7.95 | 7.32 | 6.09 | 5.18 |
Current Portion of Leases | - | - | 0 | - | - |
Current Income Taxes Payable | 0.11 | 0.79 | 0.67 | 0.69 | 1.52 |
Other Current Liabilities | - | 1.33 | - | - | - |
Total Current Liabilities | 18.25 | 27.26 | 25.07 | 24.17 | 29.09 |
Long-Term Debt | - | - | - | 0.72 | - |
Long-Term Leases | - | - | 0 | - | - |
Total Liabilities | 18.25 | 27.26 | 25.08 | 24.9 | 29.09 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.03 | 0.02 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 59.64 | 49.22 | 42.97 | 42.97 | 9.72 |
Retained Earnings | 128.25 | 121.47 | 110.62 | 99 | 92.75 |
Treasury Stock | -0.2 | -0.2 | - | - | - |
Comprehensive Income & Other | 1.21 | -11.53 | -7.27 | -3.85 | 5.29 |
Total Common Equity | 188.93 | 158.98 | 146.33 | 138.12 | 107.77 |
Minority Interest | - | - | 0.51 | 0.56 | - |
Shareholders' Equity | 188.93 | 158.98 | 146.84 | 138.68 | 107.77 |
Total Liabilities & Equity | 207.18 | 186.24 | 171.92 | 163.58 | 136.86 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 8.99 | 7.95 | 7.33 | 6.81 | 5.18 |
Net Cash (Debt) | 6.17 | 8.01 | 8.23 | 19.92 | 2.97 |
Net Cash Growth | -23.05% | -2.62% | -58.69% | 570.59% | -25.15% |
Net Cash Per Share | 16.40 | 29.28 | 34.38 | 85.10 | 14.85 |
Filing Date Shares Outstanding | 0.7 | 0.32 | 0.25 | 0.24 | 0.24 |
Total Common Shares Outstanding | 0.7 | 0.32 | 0.24 | 0.24 | 0.2 |
Working Capital | 135.33 | 116.17 | 107.16 | 111.15 | 68.19 |
Book Value Per Share | 271.61 | 501.94 | 611.24 | 576.95 | 538.84 |
Tangible Book Value | 188.48 | 158.53 | 142.42 | 137.63 | 107.21 |
Tangible Book Value Per Share | 270.97 | 500.54 | 594.89 | 574.88 | 536.03 |
Buildings | 9.48 | 9.09 | 9.33 | 7.34 | 9.55 |
Machinery | 3.24 | 3.08 | 3.22 | 3.8 | 3.85 |
Construction In Progress | - | - | 0.13 | 1.39 | 0.66 |